News & Press Releases

Mintz represented ArriVent Biopharma in a $155 Million Series B financing led by Sofinnova Investments and General Catalyst to fund studies of the company's EGFR kinase inhibitor furmonertinib. Members Ed Pease and Private Equity Practice Co-Chair Matthew Simpson led the Mintz team's work on the transaction.

BOSTON – Mintz is pleased to announce that two of its attorneys have been included in Massachusetts Lawyers Weekly 2023 ‘Excellence In Law’ recognition.

SAN DIEGO – Mintz is pleased to announce that four attorneys have been named San Diego Super Lawyers and three have been recognized as Rising Stars in the 2023 edition of the annual publication.

Boston, MA – Mintz is pleased to announce that Michael T. Renaud, Chair of the Intellectual Property Division, and the firm’s International Trade Commission (ITC) Practice have been shortlisted in the 2023 edition of Managing Intellectual Property’s (MIP) Americas Awards. The awards recognize the “remarkable achievements and developments” of firms, individuals and companies impacting the IP sector over the past year.

BOSTON, TORONTO – Mintz  is pleased to announce its expansion into Canada with the opening of a Toronto office, launched by a team of highly regarded and industry-leading attorneys. The new office will add depth and breadth to Mintz’s global Life Sciences practice and will further expand the firm’s strong Private Equity, Capital Markets, and Pensions and Employment practices.

Deal activity remains high for our Energy & Sustainability Practice, building on the momentum of last year’s record of 57 transactions with an aggregate deal value of $4.6 billion. Global investment into energy transition and climate technology drove our work for clients like NET Power, Nuvve Corporation, and Aspen Aerogels.